Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
RadNet, Inc. RDNT
$26.82
-$0.19 (-0.70%)
На 18:00, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
1582090935.00000000
-
week52high
29.47
-
week52low
12.03
-
Revenue
1430061000
-
P/E TTM
49
-
Beta
1.64256000
-
EPS
0.17000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 12:30
Описание компании
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Raymond James | Market Perform | Outperform | 12 авг 2021 г. |
| Barclays | Overweight | 12 авг 2021 г. | |
| Raymond James | Outperform | Outperform | 09 мар 2021 г. |
| Raymond James | Outperform | Outperform | 11 авг 2020 г. |
| Sidoti & Co. | Buy | Buy | 26 мая 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| STOLPER MARK | A | 27276 | 27276 | 03 янв 2023 г. |
| STOLPER MARK | A | 14073 | 14073 | 03 янв 2023 г. |
| Murdock Michael N | A | 83547 | 15790 | 03 янв 2023 г. |
| Patel Mital | A | 29891 | 29891 | 03 янв 2023 г. |
| Patel Mital | A | 211550 | 15423 | 03 янв 2023 г. |
| Katz David Jeffrey | A | 29891 | 29891 | 03 янв 2023 г. |
| Katz David Jeffrey | A | 15423 | 15423 | 03 янв 2023 г. |
| BERGER HOWARD G | A | 103969 | 103969 | 03 янв 2023 г. |
| BERGER HOWARD G | A | 53648 | 53648 | 03 янв 2023 г. |
| Forthuber Stephen M | A | 33789 | 33789 | 03 янв 2023 г. |
Новостная лента
RadNet (RDNT) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
09 мая 2023 г. в 09:10
RadNet (RDNT) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.15 per share a year ago.
RadNet, Inc. Announces Date of its First Quarter 2023 Financial Results Conference Call
GlobeNewsWire
27 апр 2023 г. в 06:00
LOS ANGELES, April 27, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its first quarter 2023 financial results on Tuesday, May 9, 2023 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
RadNet: In For A Big FY 2023, Look For De Novo Contributions
Seeking Alpha
19 апр 2023 г. в 13:05
RadNet, Inc. has projected itself to have a strong FY'23 from a period of heavy investment last year. The firm has added numerous de novos and expects to bring more online this year.
3 Medical Device Stocks With Potential to Fight Recession Risk
Zacks Investment Research
28 мар 2023 г. в 10:44
Increasing interest rates, higher costs and rising unemployment paint an unfavorable picture with the risk of a recession looming large. Here we discuss three medical stocks that may be good bets even in a recession.
4 Promising Stocks From a Challenging Outpatient Home Health Industry
Zacks Investment Research
23 мар 2023 г. в 12:13
Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. CHE, ADUS, RDNT and PNTG are well poised to gain from the prospects.